Health Care/Hospital

Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss First Quarter Results of Fiscal Year 2008

WEIFANG, China, Nov. 9 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China and glucose and starch product...

2007-11-09 21:00 655

China Sky One Medical Completes Previously Announced Amendment to 2006 Form 10KSB

HARBIN, China, Nov. 8 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced that it has completed the previously announced amendment to the C...

2007-11-09 05:01 499

China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter FY 2008 Results

SHANGHAI, China, Nov. 8 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT), a leading Chinese firm specializing in the research, development, manufacture, marketing and distribution of probiotics dietary supplements, today announced it will conduct a conference c...

2007-11-08 22:00 569

Fenofibrate - First Lipid Modifying Agent Shown to Protect Diabetic Eye

SYDNEY, Australia, Nov. 8 /Xinhua-PRNewswire/ -- In the Lancet, on Tuesday, November, 6th new results of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) 2007 clinical trial have been published and presented on the same date at a press conference held during the AHA. ...

2007-11-08 08:01 497

Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007

BETHESDA, Md. Nov. 8 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX), an independent American provider of Western healthcare services and products in the People’s Republic of China, today announced profitable results for the quarter and six months ended September 30, 2007, incl...

2007-11-08 07:00 779

Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million

BEIJING and CLAREMONT, Calif., Nov. 7 /Xinhua-PRNewswire/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced that revenues for the first nine months of 2007 were $6,214,712 an increase of 567% over $930,442 in the first nine months of 2006. Revenues for the ...

2007-11-08 06:16 472

JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc.

$50 Million Investment to Finance Growth in Chindex's Healthcare Network in China BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) a leading independent American provider of Western healthcare services and products in the People's Republic of China, toda...

2007-11-07 22:44 718

Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients

PHILADELPHIA and BASINGSTOKE, England, Nov. 6 /Xinhua-PRNewswire/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) today announced the results of a Phase II study indicating that FOSRENOL can effectively reduce serum phosphate levels in chronic kidney disease (CKD) patients not on dialys...

2007-11-06 23:04 560

Mindray Medical Announces Highlights for its 2007 Analyst & Investor Day

SHENZHEN, China, Nov. 6 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced key highlights from its 2007 Analyst & Investor Day...

2007-11-06 21:30 727

Fenofibrate - First Lipid Modifying Agent Shown to Protect Diabetic Eye

SYDNEY, Australia, Nov. 6 /Xinhua-PRNewswire/ -- - First Lipid Modifying Agent Shown to Reduce Risk of Leading Causes of Blindness and Deteriorating Vision in Patients With Type 2 Diabetes - Reduces Need for Laser Treatment in Patients With and Without Known ...

2007-11-06 08:26 687

Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine

PARIS, Nov. 6 /Xinhua-PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today positive results in the development of a vaccine for the global prevention of dengue fever, one of the most widespread tropical diseases. The results are being presented today at t...

2007-11-06 16:00 597

Simcere Pharmaceutical Group Reports Third Quarter 2007 Results

Net Income Increased 73% Year-over-year or 89% Year-to-date NANJING, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product...

2007-11-05 20:00 594

In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack

Investigational compound reduces risk of major cardiovascular events by 19 percent, significantly improves net clinical benefit despite increased bleeding TOKYO and INDIANAPOLIS, Nov. 5 /Xinhua-PRNewswire/ -- In the pivotal Phase III head-to-head TRITON TIMI-38 clinical trial, the investiga...

2007-11-05 13:05 482

Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel

Duke Clinical Research Institute to lead multinational study with investigational compound; will include 10,000 medically managed patients with acute coronary syndrome TOKYO and INDIANAPOLIS, Nov. 5 /Xinhua-PRNewswire/ -- A large Phase III clinical trial is anticipated to begin in the secon...

2007-11-05 13:00 395

New Non-Clinical Data Links DYNEPO(R) (Epoetin Delta) to Reduced Angiogenic Potential

BASINGSTOKE, England, Nov. 5 /Xinhua-PRNewswire/ -- New data presented today at the 40th annual American Society of Nephrology (ASN) meeting and scientific exposition in San Francisco, CA, USA, show that epoetin delta -- the only erythropoiesis-stimulating agent (ESA) produced in a human cell li...

2007-11-05 16:00 445

Pharmaxis to Expand Manufacturing Capacity

SYDNEY, Australia, Nov. 2 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced moves to expand its manufacturing capacity with the signing of an agreement for the construction of a new state of the art facility at Frenchs Forest, Sydney. Following complet...

2007-11-02 21:00 419

Mindray Announces Appointment of Dr. Jixun Lin as Independent Director

SHENZHEN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced the appointment of Dr. Jixun Lin as independent dir...

2007-11-02 05:10 725

Mindray Medical International Announces Third Quarter 2007 Results

Company Achieves Record Revenue Growth of 58.9% Year-over-Year SHENZHEN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, t...

2007-11-02 05:00 570

Skystar Bio-Pharmaceutical Receives Award for Avian Coccidiosis Vaccine Project

XI’AN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar", “Company”), a leading bio-pharmaceutical company in the People’s Republic of China ("PRC"), today announced that the Company was awarded the National High Technol...

2007-11-01 20:30 1043

Breaking News About Treatment of World’s Leading Cause of Adult Blindness to be Published Next Week

BRUSSELS, Belgium, Nov. 1 /Xinhua-PRNewswire/ -- First study to investigate the protective effect of a lipid-lowering agent on diabetic eye disease to be published on-line in Lancet, Tuesday, 6th November 2007 Diabetic eye disease (called diabetic retinopathy) is the leading cause of vi...

2007-11-01 08:40 542
1 ... 716717718719720721722 ... 740